Sectra AB Class B AI Stock Analysis
Want to see SE:SECT.B full AI Analyst Report?
Sectra AB Class B (SECT.B) AI Stock Analysis
Sectra AB Class B
(Nasdaq OMX AB:SECT.B)
The score is driven primarily by strong financial quality (profitability and a very low-leverage balance sheet) and supportive uptrend/momentum signals. The main constraint is valuation: a very high P/E and low dividend yield reduce the risk-adjusted attractiveness despite solid fundamentals.
Sectra AB Class B (SECT.B) vs. iShares MSCI Sweden ETF (EWD)
- Market Cap
- SEK 62.79B
- Dividend Yield
- 0.71%
- Average Volume (3M)
- 185.16K
- Price to Earnings (P/E)
- 98.4
- Beta (1Y)
- 0.46
- Revenue Growth
- 13.94%
- EPS Growth
- 5.70%
- Country
- Sweden
- Employees
- 1,403
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Sectra AB Class B Business Overview & Revenue Model
Company Description
Sectra AB (publ), a Swedish company established in Linköping in 1957, specializes in providing advanced information technology solutions for both the medical and cybersecurity fields. Its services are predominantly offered across Europe, including ke...
How the Company Makes Money
Sectra makes money primarily by selling and supporting software and systems in two main areas: (1) Medical imaging IT and (2) secure communications. In its medical imaging business, Sectra generates revenue from supplying imaging and workflow softwar...
Sectra AB Class B Financial Statement Overview
Summary
Strong overall fundamentals supported by high profitability (net margin ~16.6%, operating profitability >~20%) and a very conservative balance sheet (low debt/equity ~0.055, strong return on shareholder capital ~30%). Offsets are moderating revenue growth (~5.6% TTM) and a year-over-year decline in free cash flow (~-14% TTM), which slightly reduces confidence in consistency.
Income Statement
82Very PositiveBalance Sheet
90Very PositiveCash Flow
74Positive| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.74B | 3.54B | 3.24B | 2.96B | 2.35B | 1.95B |
| Gross Profit | 924.81M | 714.42M | 543.41M | 557.55M | 488.91M | 1.71B |
| EBITDA | 843.14M | 778.66M | 842.12M | 654.12M | 573.39M | 477.28M |
| Net Income | 618.99M | 563.78M | 563.37M | 428.39M | 374.96M | 314.79M |
Balance Sheet | ||||||
| Total Assets | 4.49B | 4.47B | 3.76B | 3.21B | 2.74B | 2.19B |
| Cash, Cash Equivalents and Short-Term Investments | 1.75B | 1.81B | 1.34B | 804.64M | 945.24M | 808.77M |
| Total Debt | 127.64M | 76.48M | 87.46M | 31.79M | 82.26M | 62.62M |
| Total Liabilities | 2.17B | 2.34B | 1.84B | 1.64B | 1.44B | 1.11B |
| Stockholders Equity | 2.32B | 2.14B | 1.92B | 1.57B | 1.30B | 1.08B |
Cash Flow | ||||||
| Free Cash Flow | 848.87M | 1.01B | 812.37M | 75.58M | 347.70M | 542.55M |
| Operating Cash Flow | 981.92M | 1.10B | 922.36M | 326.33M | 440.49M | 616.92M |
| Investing Cash Flow | -230.54M | -207.46M | -113.86M | -130.74M | -212.79M | -68.35M |
| Financing Cash Flow | -430.11M | -428.43M | -251.88M | -222.20M | -219.29M | -198.75M |
Sectra AB Class B Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:SECT.B, the sentiment is Positive. The current price of 327.40 is below the 20-day moving average (MA) of 329.04, above the 50-day MA of 307.82, and above the 200-day MA of 266.57, indicating a neutral trend. The MACD of 3.24 indicates Positive momentum. The RSI at 51.30 is Neutral, neither overbought nor oversold. The STOCH value of 20.73 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:SECT.B.
Sectra AB Class B Peers Comparison
Overall Rating
SE:CEVI83Outperform
SE:SECT.B74Outperform
SE:GETI.B67Neutral
SE:XVIVO64Neutral
SE:VITR63Neutral
SE:MNTC51Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 83Outperform | SEK 4.85B | 35.21 | 15.23% | 1.35% | 1.95% | -8.91% | |
| 74Outperform | SEK 62.79B | 98.41 | 30.26% | 0.71% | 13.94% | 5.70% | |
| 67Neutral | SEK 76.70B | 27.10 | 9.13% | 1.69% | -3.90% | 37.73% | |
| 64Neutral | SEK 6.49B | 50.37 | 5.89% | ― | 17.83% | 330.94% | |
| 63Neutral | SEK 16.15B | -3.26 | -61.57% | 0.92% | -1.94% | -1223.74% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | SEK 455.64M | -24.13 | -15.00% | ― | 11.18% | 60.51% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SE:SECT.B | Sectra AB Class B | 327.40 | 46.64 | 16.61% | |
| SE:GETI.B | Getinge AB (UK) | 282.30 | 80.16 | 39.66% | |
| SE:VITR | Vitrolife AB | 119.10 | -18.98 | -13.75% | |
| SE:CEVI | CellaVision AB | 203.50 | 53.24 | 35.43% | |
| SE:XVIVO | Xvivo Perfusion AB | 198.40 | 36.00 | 22.17% | |
| SE:MNTC | Mentice AB | 16.90 | 3.60 | 27.07% |
Sectra AB Class B Corporate Events
Sectra Breaks SEK 1 Billion Mark in Cloud Recurring Revenue
Sectra reported that its rolling 12-month cloud recurring revenue passed SEK 1 billion for the first time, driven by strong historical order bookings and long-term investments in scalable cloud services. The company’s recurring revenue now makes up a...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 07, 2026
